Liminatus Pharma, Inc Class A Common Stock

Yahoo Finance • 2 months ago

Wondering what's happening in today's pre-market session?

Wondering what's happening in Friday's pre-market session? Find an overview in this article. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT EEIQ [https://www.chartmill.com/stock/quote/EEIQ/profile] 127.0% EPICQUEST... Full story

Yahoo Finance • 2 months ago

Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative

LA PALMA, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced plans for a strateg... Full story

Yahoo Finance • 3 months ago

Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy

LA PALMA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced it has entered into... Full story

Yahoo Finance • 3 months ago

Get insights into the top gainers and losers of Thursday's pre-market session.

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. [premarket] GAINERS TICKER CHANGE COMMENT LIDR [https://www.chartmill.com/st... Full story

Yahoo Finance • 3 months ago

Liminatus gains amid review to consider digital assets for treasury management

[Glowing dollar symbol, cryptocurrency network, neon green dollar symbol, blue blockchain links, futuristic finance tech, global economy, cyberpunk aesthetic. 3D render.] * Liminatus Pharma (NASDAQ:LIMN [https://seekingalpha.com/symbol/... Full story

Yahoo Finance • 3 months ago

Liminatus Pharma explores digital asset treasury strategy

Liminatus Pharma, Inc. (LIMN) announced it has initiated a strategic review to evaluate the potential inclusion of regulated digital asset strategies in its treasury management framework. The preclinical-stage biopharmaceutical company, w... Full story

Yahoo Finance • 3 months ago

Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy

LA PALMA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced that it has initiat... Full story

Yahoo Finance • 3 months ago

Liminatus Pharma appoints Philip Lemons and Richard Baek to board of directors

Liminatus Pharma, Inc. (NASDAQ:LIMN), a $173 million market cap pharmaceutical company, announced Thursday that its board of directors has expanded to six members with the appointment of Philip Lemons and Richard Baek as directors, effecti... Full story

Yahoo Finance • 3 months ago

Liminatus Pharma forms consortium for pancreatic cancer diagnostic kit

Liminatus Pharma, Inc. (NASDAQ:LIMN), a $245 million market cap biotech company whose stock has declined nearly 47% in the past week, announced Wednesday that it has entered into a memorandum of understanding to form a research and develop... Full story

Yahoo Finance • 4 months ago

Liminatus Pharma stock gains on regaining compliance with Nasdaq

[A graph moving up] Richard Drury * Liminatus Pharma (NASDAQ:LIMN [https://seekingalpha.com/symbol/LIMN]) shares rose after the company said it regained compliance with Nasdaq's listing needs [https://seekingalpha.com/filing/10070728].... Full story